Instil Bio Inc. (TIL)
NASDAQ: TIL
· Real-Time Price · USD
28.25
1.28 (4.75%)
At close: Aug 14, 2025, 3:59 PM
28.99
2.64%
Pre-market: Aug 15, 2025, 04:39 AM EDT
4.75% (1D)
Bid | 25 |
Market Cap | 185.29M |
Revenue (ttm) | n/a |
Net Income (ttm) | -78.03M |
EPS (ttm) | -11.97 |
PE Ratio (ttm) | -2.36 |
Forward PE | -2.13 |
Analyst | Buy |
Ask | 29.88 |
Volume | 91,870 |
Avg. Volume (20D) | 324,498 |
Open | 25.90 |
Previous Close | 26.97 |
Day's Range | 25.90 - 28.55 |
52-Week Range | 9.90 - 92.00 |
Beta | 2.17 |
Analyst Forecast
According to 0 analyst ratings, the average rating for TIL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+8.57%
Instil Bio shares are trading higher after the com...
Unlock content with
Pro Subscription
7 months ago
+14.84%
Instil Bio shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $11 to $52.

2 months ago · seekingalpha.com
Instil Bio: Second-Half 2025 AXN-2510 Data Could Mark Another PD-1/VEGF SuccessKey catalyst: Phase 2 data from China in first-line NSCLC expected in 2H 2025, with enrollment completion projected for Q3 2025. The global non-small cell lung cancer therapeutics market size is proje...